Influence of the M235T angiotensinogen and I/D angiotensin converting enzyme polymorphisms on hypertension and other cardiovascular risk factors;Influencia de los polimorfismos M235T del angiotensinógeno e I/D de la enzima conversiva de la angiotensina sobre la hipertensión arterial y otros factores de riesgo cardiovascular

Medicina Clinica

Volumn 113, Issue 5, 1999, Pages 164-168

  Pamies Andreu, Encarnación ^a,b   Palmero, César Palmero ^a   Lozano, Raúl García ^b   García Junco, Pablo Stiefel ^a   Guisado, María Luisa Miranda ^a   Sanz, Val Martín ^a   Ortiz, José Villar ^a   Roldán, Antonio Núñez ^b   De La Fuente, Joaquín Carneado ^a  

^a Departamento de Medicina Interna   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Cardiovascular risk factors; Hypertension; I D polymorphisms; M235T polymorphisms

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; LIPID;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DNA PROBE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; ANGIOTENSINOGEN; CARDIOVASCULAR DISEASES; DNA PROBES; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0033542591     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. En: Laragh JH, Brenner BM, editores. Hypertension: pathophysiology, diagnosis and management. Nueva York: Raven Press Publisher, 1990; 1.287-1.317.
2. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
3. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93: 1.285-1.287.
4. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the japanese population. Hypertension 1995; 25: 688-693.
5. Caulfield M, Lavender P, Farrali M, Munroe P, Lawson M, Turner P et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1.629-1.633.
6. Rotimi C, Morrison L, Cooper R, Oyejide C, Effong E, Ladipo M et al. Angiotensinogen gene in human hypertension: lack of an association of the 235T among African Americans. Hypertension 1994; 24: 591-594.
7. Hingorani AD, Sharma P, Haiyan J, Hooper R, Brown MJ. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996; 28: 907-911.
8. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesaniemi YA et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996; 28: 1.070-1.075.
9. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in whites. A systematic review and methodological appraisal. Hypertension 1997; 30: 1.331-1.337.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Convol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1.343-1.346.
11. Rigat B, Hubert C, Corvo P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase). Nucleic Acids Res 1992; 20: 1.433.
12. Zee RYL, Lou Y, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184: 9-15.
13. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-460.
14. Schmidt S, VanHooft IMS, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch hypertension and offspring study. J Hypertens 1993; 11: 345-348.
15. Vassilikioti S, Doumas M, Doumas S, Petidis K, Karagiannis A, Balaska K et al. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hyperten 1996; 9: 700-702.
16. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
17. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F et al. The deletion/-insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15: 1.579-1.592.
18. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994; 12: 955-957.
19. Fernández-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A et al. Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 1998; 53: 1.743-1.747.
20. Martínez E, Puras A, Sanchis C, Carrión L, Fernández JA, Escribano J et al. Genética de la hipertensión en una población española. Resultados de un estudio epidemiológico poblacional con un diseño caso-control. Hipertensión 1998; 15: 150-151.
21. Fernández-Llama P, Poch E, Oriola J, Botey A, Rivera F, Revert L. Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension. Relation with target organ damage. Am J Hypertens 1998; 11: 439-444.
22. Kawasaki E. Sample preparation from blood cell and other fluids. En: Innis M, Gelfand D, Sninsky J, White T, editores. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990; 48.
23. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet 1994; 343: 851.
24. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2.503-2.516.
25. Kageyama R, Ohkubo H, Nakanishi S. Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 1984; 23: 3.603-3.609.
26. Fernández-Viña MA, Bignon JD. Primers and oligonucleotide probes (SSOP) used for DNA typing for DNA of HLA class II alelles. En: Charon, editor. Genetic diversity of HLA functional and medical implication. Paris: EDK, 1997; 5.596-5.632.
27. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998; 97: 1.773-1.779.
28. O'Donnell CJ, Lindpaintner K, Larson MG, Rao WS, Ordovás JM, Schaefer EJ et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation 1998; 97: 1.776-1.779.
29. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hy-pertrophy. N Engl J Med 1994; 330: 1.634-1.638.
30. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2.622-2.628.
31. Lindpaintner K, Lee M, Larson MC, Rao VS, Pfeffer MA, Ordovás JM et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334: 1.023-1.028.
32. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341: 991-992.
33. Espinosa JS, Rueda E, Muñoz E, Montiel A, Martínez S, Diéguez JL et al. Asociación entre polimorfismo inserción/deleción del gen codificador de la enzima conversiva de angiotensina e infarto de miocardio en pacientes jóvenes. Med Clin (Barc) 1998; 110: 488-491.
34. Badenhop RF, Wang XL, Wilcken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995; 91: 1.655-1.658.
35. Panahloo A, Andrés C, Mohamed-Alí V, Gould MM, Talmud P, Humphries SE et al. The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 1995; 92: 3.390-3.393.
36. Hiraga H, Oshima T, Watanabe M. Angiotensin I converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996; 27: 569-572.
37. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M et al. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 1997; 30: 1.325-1.330.
38. Busjahn A, Knoblauch H, Knoblauch M, Bohlender J, Menz M, Faulhaber HD et al. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study. Hypertension 1997; 29: 165-170.